Cargando…
Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus
BACKGROUND: A relationship between hyperthyroidism and insulin secretion in type 2 diabetes mellitus (T2DM) has been reported. Therefore, this study explored the use of first-phase insulin secretion in the differential diagnosis of thyroid diabetes (TDM) and T2DM. METHODS: In total, 101 patients wit...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381313/ https://www.ncbi.nlm.nih.gov/pubmed/28345543 http://dx.doi.org/10.4103/0366-6999.202739 |
_version_ | 1782519914972577792 |
---|---|
author | Meng, Li-Heng Huang, Yao Zhou, Jia Liang, Xing-Huan Xian, Jing Li, Li Qin, Ying-Fen |
author_facet | Meng, Li-Heng Huang, Yao Zhou, Jia Liang, Xing-Huan Xian, Jing Li, Li Qin, Ying-Fen |
author_sort | Meng, Li-Heng |
collection | PubMed |
description | BACKGROUND: A relationship between hyperthyroidism and insulin secretion in type 2 diabetes mellitus (T2DM) has been reported. Therefore, this study explored the use of first-phase insulin secretion in the differential diagnosis of thyroid diabetes (TDM) and T2DM. METHODS: In total, 101 patients with hyperthyroidism were divided into hyperthyroidism with normal glucose tolerance (TNGT), hyperthyroidism with impaired glucose regulation (TIGR), and diabetes (TDM) groups. Furthermore, 96 patients without hyperthyroidism were recruited as control groups (normal glucose tolerance [NGT], impaired glucose regulation [IGR], and T2DM). The following parameters were evaluated: homeostasis model assessment (HOMA)-IR, HOMA-β, modified β-cell function index (MBCI), peak insulin/fasting insulin (I(P)/I(0)), AUC(ins-OGTT), and AUC(ins-OGTT)/AUC(glu-OGTT) from the oral glucose tolerance test (OGTT) insulin release test were utilized to assess the second-phase insulin secretion, while the I(P)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) from the intravenous glucose tolerance test (IVGTT) insulin release test were used to assess the first-phase insulin secretion. RESULTS: In the OGTT, the HOMA-β values of the TNGT and TDM groups were higher than those of the NGT and T2DM groups (all P < 0.05). In the hyperthyroidism groups, the MBCI of the TDM group was lower than that of the TNGT and TIGR groups (all P < 0.05). Among the control groups, the MBCI values of the IGR and T2DM groups were lower than that of the normal glucose tolerance (NGT) group (all P < 0.05). In the IVGTT, insulin secretion peaked for all groups at 2–4 min, except for the T2DM group, which showed a low plateau and no secretion peak. The I(P) values of the TNGT, TIGR, and TDM groups were higher than those of the NGT, IGR, and T2DM groups (all P < 0.05). The I(p)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) values of the TDM group were higher than those of the T2DM group but were lower than those of the TNGT, TIGR, NGR, and IGR groups (all P < 0.05). Compared with the other five groups, the I(p)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) values of the T2DM group were significantly decreased (all P < 0.05). The I(p)/I(0) and AUC(ins-IVGTT) values of the TNGT group were higher than those of the NGT group (all P < 0.05). CONCLUSIONS: β-cell function in TDM patients is superior to that in T2DM patients. First-phase insulin secretion could be used as an early diagnostic marker to differentiate TDM and T2DM. |
format | Online Article Text |
id | pubmed-5381313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-53813132017-04-26 Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus Meng, Li-Heng Huang, Yao Zhou, Jia Liang, Xing-Huan Xian, Jing Li, Li Qin, Ying-Fen Chin Med J (Engl) Original Article BACKGROUND: A relationship between hyperthyroidism and insulin secretion in type 2 diabetes mellitus (T2DM) has been reported. Therefore, this study explored the use of first-phase insulin secretion in the differential diagnosis of thyroid diabetes (TDM) and T2DM. METHODS: In total, 101 patients with hyperthyroidism were divided into hyperthyroidism with normal glucose tolerance (TNGT), hyperthyroidism with impaired glucose regulation (TIGR), and diabetes (TDM) groups. Furthermore, 96 patients without hyperthyroidism were recruited as control groups (normal glucose tolerance [NGT], impaired glucose regulation [IGR], and T2DM). The following parameters were evaluated: homeostasis model assessment (HOMA)-IR, HOMA-β, modified β-cell function index (MBCI), peak insulin/fasting insulin (I(P)/I(0)), AUC(ins-OGTT), and AUC(ins-OGTT)/AUC(glu-OGTT) from the oral glucose tolerance test (OGTT) insulin release test were utilized to assess the second-phase insulin secretion, while the I(P)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) from the intravenous glucose tolerance test (IVGTT) insulin release test were used to assess the first-phase insulin secretion. RESULTS: In the OGTT, the HOMA-β values of the TNGT and TDM groups were higher than those of the NGT and T2DM groups (all P < 0.05). In the hyperthyroidism groups, the MBCI of the TDM group was lower than that of the TNGT and TIGR groups (all P < 0.05). Among the control groups, the MBCI values of the IGR and T2DM groups were lower than that of the normal glucose tolerance (NGT) group (all P < 0.05). In the IVGTT, insulin secretion peaked for all groups at 2–4 min, except for the T2DM group, which showed a low plateau and no secretion peak. The I(P) values of the TNGT, TIGR, and TDM groups were higher than those of the NGT, IGR, and T2DM groups (all P < 0.05). The I(p)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) values of the TDM group were higher than those of the T2DM group but were lower than those of the TNGT, TIGR, NGR, and IGR groups (all P < 0.05). Compared with the other five groups, the I(p)/I(0), AIR(0′~10′), and AUC(ins-IVGTT) values of the T2DM group were significantly decreased (all P < 0.05). The I(p)/I(0) and AUC(ins-IVGTT) values of the TNGT group were higher than those of the NGT group (all P < 0.05). CONCLUSIONS: β-cell function in TDM patients is superior to that in T2DM patients. First-phase insulin secretion could be used as an early diagnostic marker to differentiate TDM and T2DM. Medknow Publications & Media Pvt Ltd 2017-04-05 /pmc/articles/PMC5381313/ /pubmed/28345543 http://dx.doi.org/10.4103/0366-6999.202739 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Meng, Li-Heng Huang, Yao Zhou, Jia Liang, Xing-Huan Xian, Jing Li, Li Qin, Ying-Fen Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus |
title | Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus |
title_full | Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus |
title_fullStr | Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus |
title_full_unstemmed | Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus |
title_short | Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus |
title_sort | use of first-phase insulin secretion in early diagnosis of thyroid diabetes and type 2 diabetes mellitus |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381313/ https://www.ncbi.nlm.nih.gov/pubmed/28345543 http://dx.doi.org/10.4103/0366-6999.202739 |
work_keys_str_mv | AT mengliheng useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus AT huangyao useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus AT zhoujia useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus AT liangxinghuan useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus AT xianjing useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus AT lili useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus AT qinyingfen useoffirstphaseinsulinsecretioninearlydiagnosisofthyroiddiabetesandtype2diabetesmellitus |